Skip to contentX
Xenetic Biosciences, Inc.
X
XBIOXenetic Biosciences, Inc. Q3 2016 · 10-Q
Revenue$0.00$0.00no prior Q3 2015 on file Net Income-$2.47M-$2.47MN/M vs Q3 2015 EPS Diluted-$0.28-$0.28N/M vs Q3 2015 Operating Income-$2,251,629N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Xenetic Biosciences, Inc. · CIK 1534525 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$1,028,890N/M ended Sep 30, 2016 · filed Nov 14, 2016 · 45 d after period end